|1.||Li, Andrew Y: 2 articles (08/2015 - 04/2005)|
|2.||Miller, Robert J: 2 articles (08/2015 - 03/2007)|
|3.||George, John E: 2 articles (03/2007 - 04/2005)|
|4.||Calatayud, Fernando: 1 article (01/2016)|
|5.||Picó, Yolanda: 1 article (01/2016)|
|6.||Simó, Enrique: 1 article (01/2016)|
|7.||Calatayud-Vernich, Pau: 1 article (01/2016)|
|8.||Suarez-Varela, Maria Morales: 1 article (01/2016)|
|9.||Black, Michael: 1 article (08/2015)|
|10.||Moolhuijzen, Paula M: 1 article (08/2015)|
|1.||Body Weight (Weight, Body)
05/01/2007 - "Coumaphos topically administered at 1 mg/kg body weight per day to cattle under normal management practices in tropical areas produced a significant inhibition in erythrocyte (RBC) AChE and BuAChE activities when compared to baseline levels. "
04/01/1988 - "Doses were administered, along the dorsal midline from withers to sacrum, at a rate equivalent to 14 mg of coumaphos/kg of body weight. "
11/01/1980 - "The LD50 for EsA- lambs was 763 mg/kg of body weight with 95% confidence limits of 543 to 1,072 mg/kg. The acute oral LD50 for EsA+ lambs remains undetermined but was demonstrated to be in excess of 11,392 mg/kg. The acute oral LD50 for a closely related organophosphate (coumaphos) was not different in the 2 phenotypes of sheep."
06/01/1976 - "Coumaphos crumbles (0.32%) administered to cattle at the dose level of 2 mg of active ingredient per kilogram of body weight each day for 6 days reduced fecal egg counts by 98.4%. "
03/01/1975 - "The effects of treating adult wethers with 2 or 4 mg of coumaphos/kg of body weight each day for 6 days were investigated. "
08/01/1990 - "In Experiment 1 treatment with ivermectin (0.2 mg/kg body weight) or coumaphos (0.05% dip solution) resulted in a significant reduction in mite numbers and an increase in body weight while in the untreated controls all animals had to be withdrawn from the experiment due to severity of infection. "
01/01/2010 - "Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS)."
10/02/2012 - "Coumaphos, an organophosphorus pesticide (OP) used worldwide, has raised serious public concerns due to its positive association with major types of cancer. "
01/01/2010 - "Coumaphos was not associated with any cancer evaluated here. "
01/01/2010 - "Cumulative exposure to coumaphos was not associated with cancer risk overall or with any major cancer site including prostate. "
01/01/2010 - "Poisson regression was used to estimate rate ratio (RR) and 95% confidence interval (CI) of cancer for coumaphos exposure controlling for potentially confounding variables. "
|5.||Prostatic Neoplasms (Prostate Cancer)
01/01/2010 - "Previous research in the Agricultural Health Study (AHS) cohort observed a positive association between coumaphos and prostate cancer in men with a family history of prostate cancer. "
01/01/2010 - "In men with a family history of prostate cancer, we observed a positive association between ever use of coumaphos and prostate cancer in both early (RR = 2.07; 95% CI, 1.19-3.62, p-interaction = 0.005) and later (RR = 1.46; 95% CI, 0.89-2.40; p-interaction = 0.11) periods of follow-up. "
01/01/2010 - "Approximately 8% of applicators reported use of coumaphos; 8.5% reported a family history of prostate cancer. "
01/01/2010 - "This study was performed to determine the association between coumaphos and other major cancer sites and to explore the consistency of the association with prostate cancer early (1993-1999) and later (2000-2005) in AHS follow-up. "
01/01/2010 - "In men with a family history of disease, there was evidence of an association between coumaphos and prostate cancer, possibly due to genetic susceptibility; however, other explanations, including chance, are plausible."
|2.||diazenedicarboxylic acid bis(N'-methylpiperazide)
|8.||Parathion (Ethyl Parathion)